Health Impact News Editor Comments:

Earlier this year we covered a new study conducted at the China Medical University in Taiwan showing how non-drug therapies such as the ketogenic diet and hyperbaric oxygen therapy were being used to cure cancer. See: Study: Ketogenic Diet and Hyperbaric Oxygen Therapy Stops Cancer. There is has been a lot of research into the use of hyperbaric oxygen treatment for cancer and other diseases lately.

So it should come as no surprise that the FDA, in an obvious effort to protect the lucrative drug market for treating cancer, has issued a statement saying that hyperbaric oxygen therapy is “not approved” by them for such treatment.

FDA Issues Deceptive Statement about HBOT (Hyperbaric Oxygen Therapy)

by Alliance for Natural Health

The agency has just issued a warning to consumers. As is so often the case, what they don’t tell you is more important than what they do tell you.

The agency’s warning begins, “No, hyperbaric oxygen therapy (HBOT) has not been clinically proven to cure or be effective in the treatment of cancer, autism, or diabetes. But do a quick search on the Internet, and you’ll see all kinds of claims for these and other diseases for which the device has not been cleared or approved by FDA.”

HBOT is approved to treat thirteen conditions: decompression sickness, thermal burns, non-healing wounds, necrotizing soft tissue infections (a.k.a. flesh-eating bacterial disease), acute traumatic ischemias (e.g., crush injury, compartment syndrome), radiation tissue damage, smoke inhalation and carbon monoxide poisoning, air or gas embolism, severe blood loss anemia, refractory osteomyelitis, compromised skin grafts, and clostridial myonecrosis (gangrene).

There are, however, many other conditions that HBOT appears to treat effectively, based on solid or promising research. Licensed physicians and healthcare institutions may legally use an FDA-cleared hyperbaric chamber to treat unapproved or “off-label” diseases and conditions, though it is illegal to promote or advertise such uses. A few doctors are already using HBOT off-label, but not nearly enough of them. Here are some of the off-label applications:

• Traumatic brain injury (TBI) and post-traumatic stress disorder (PTSD), both suffered most often by returning wounded veterans. Tragically, the Department of Defenserefuses to use HBOT off-label for veterans, claiming that they don’t prescribe off-label medications and treatments for these diagnoses, and saying they can only use HBOT after it has been approved by the FDA for this use.

This isn’t even true. The DoD often uses antipsychotic drugs off-label to treat TBI and PTSD. About 20% of veterans diagnosed with PTSD—or nearly 87,000 patients—are prescribed an antipsychotic each year even though it is an off-label use.

In total, including prescriptions outside the military, nearly 280,000 individuals received antipsychotic medications in 2007. Yet over 60% of them had no record of a diagnosis for which these drugs are approved. Antipsychotic drugs were prescribed off-label for PTSD (42% of the patients), minor depression (40%), major depression (23%), and anxiety disorder (20%)—with about 20% having more than one condition.

• Autism. You may recall our story from two years ago where we told you about the successes one mother of three autistic boys had with HBOT. This treatment, like the treatment for brain injury, was pioneered by Dr. Paul G. Harch, president of the International Hyperbaric Medical Association Foundation.

• The American Cancer Society says HBOT can help when used as a mainstream treatment for the prevention and treatment of osteoradionecrosis, a term for delayed bone damage caused by radiation therapy. There is also some evidence suggesting HBOT may be helpful as an extra treatment for soft tissue injury caused by radiation.

• The Undersea and Hyperbaric Medical Society’s Committee on Hyperbaric Oxygen Therapy also recommends it for treatment of thermal (heat) burns, abscess in the brain or head, osteomyelitis (chronic bone inflammation) that does not respond to standard treatment, and blockage of the retinal artery (blood vessel in the back of the eyeball).

• Some research indications—where HBOT is performed on a more experimental basis—include acute carbon tetrachloride poisoning, cerebral palsy, cerebrovascular accident (acute-thrombotic or embolic), fracture healing and bone grafting, hydrogen sulfide poisoning, invasive aspergillosis, sickle cell anemia crises, brown recluse spider bites, and acute spinal cord injuries.

• Stroke, Lyme disease, major viral infections, multiple sclerosis, heart disease, sinusitis, head injuries, and many other problems may respond well to HBOT, but it is rarely prescribed for any of these conditions.

Oxygen is necessary for healing. HBOT saturates tissues with ten to thirteen times as much oxygen as can normally be breathed in. Hyperbaric chambers and hyperbaric oxygen therapy have been used clinically since the mid-1800s. HBOT was tested and further developed by the US military after World War I. Today, nearly every hospital owns a hyperbaric oxygen chamber. Most of these sit empty and unused.

With so many conditions that HBOT can treat effectively, why in the world should we keep people sick or in pain when we have the means to ease and even reverse their condition? And why is FDA issuing warnings to consumers to keep them from pursuing such a vital therapy?

The FDA’s consumer warning continues that HBOT is not “the kind of universal treatment it has been touted to be on some Internet sites. FDA is concerned that some claims made by treatment centers using HBOT may give consumers a wrong impression that could ultimately endanger their health.”

The warning continues, “Patients may incorrectly believe that these devices have been proven safe and effective for uses not cleared by FDA, which may cause them to delay or forgo proven medical therapies.” “Proven medical therapies” like dangerous drugs and expensive, invasive surgery, perhaps?

This is part of the problem. The FDA tends to protect therapies that are non-natural and patentable, so that drug companies can afford to spend $1 billion on average for agency approval. Bringing these drugs through the approval process pays the agency’s bills, including salaries. Indeed much of the cost of the FDA is born directly by drug companies, which creates a huge conflict of interest.

The other piece of information left out of the FDA’s warning is that patents on HBOT tanks ran out long ago, so that bringing the therapy back for additional use approvals is very difficult if not impossible. The FDA is thus telling you not to use it for unapproved uses, but failing to disclose that other uses will likely never be approved, that pleas for government funding of HBOT research will go nowhere, and that the agency itself won’t lift a finger to do something about this situation, no matter how much human suffering this policy creates.

Read the full article here: http://www.anh-usa.org/fda-deceptive-hbot/

We Lost the War on Cancer – Review of Alternative Cancer Therapies

eBook
Retail : $9⁹⁹
Now : $5⁹⁹

We have lost the war on cancer. At the beginning of the last century, one person in twenty would get cancer. In the 1940s it was one out of every sixteen people. In the 1970s it was one person out of ten. Today one person out of three gets cancer in the course of their life.

The cancer industry is probably the most prosperous business in the United States. In 2014, there will be an estimated 1,665,540 new cancer cases diagnosed and 585,720 cancer deaths in the US. $6 billion of tax-payer funds are cycled through various federal agencies for cancer research, such as the National Cancer Institute (NCI). The NCI states that the medical costs of cancer care are $125 billion, with a projected 39 percent increase to $173 billion by 2020.

The simple fact is that the cancer industry employs too many people and produces too much income to allow a cure to be found. All of the current research on cancer drugs is based on the premise that the cancer market will grow, not shrink.

John Thomas explains to us why the current cancer industry prospers while treating cancer, but cannot afford to cure it in Part I. In Part II, he surveys the various alternative cancer therapies that have been proven effective, but that are not approved by the FDA.

Purchase the DVD – Free Shipping Available! Click image to view the trailer.